Werewolf Therapeutics

HOWL59

Penny Stock

$1.93arrow_drop_down5.36%-$0.10

Penny Stock

HOWL59

$1.93

arrow_drop_down5.36%-$0.10

Penny Stock

Performance History

Key Stats
Open	$2.18
Prev. Close	$2.20
EPS	-1.38
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$93.95M
PE Ratio	-

	LOW	HIGH
Day Range	2.13	2.27
52 Week Range	1.57	8.19

Ratios







EPS	-1.38

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Werewolf Therapeutics (HOWL)

Werewolf Therapeutics, Inc., trading under the ticker symbol HOWL, is a biotechnology company that specializes in developing innovative therapies for cancer treatment. The company's primary focus is on utilizing its unique proprietary platform to design and develop a new class of therapeutics known as werewolf immunomodulators. These werewolf immunomodulators are designed to activate and enhance the body's own immune system to fight and eradicate cancer cells.

Werewolf Therapeutics, Inc. is committed to revolutionizing cancer treatment by addressing the limitations of existing immunotherapies. The company's proprietary platform enables the selective targeting of specific tumor microenvironments, allowing for precise delivery of therapeutics to the tumor site. This targeted approach enhances the efficacy of treatment while minimizing off-target effects and reducing systemic toxicity.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Daniel J. Hicklin Ph.D.
Headquarters: Watertown
Employees: 48
Exchange: NASDAQ

Keep an eye on Werewolf Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Werewolf Therapeutics's (HOWL) price per share?

The current price per share for Werewolf Therapeutics (HOWL) is $1.93. The stock has seen a price change of -$0.11 recently, indicating a -5.37% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Werewolf Therapeutics (HOWL)?

For Werewolf Therapeutics (HOWL), the 52-week high is $8.19, which is 324.56% from the current price. The 52-week low is $1.57, the current price is 22.62% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Werewolf Therapeutics (HOWL) a growth stock?

Werewolf Therapeutics (HOWL) has shown an average price growth of -3.55% over the past three years. It has received a score of 14 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Werewolf Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Werewolf Therapeutics (HOWL) stock price performance year to date (YTD)?

As of the latest data, Werewolf Therapeutics (HOWL) has a year-to-date price change of -58.41%. Over the past month, the stock has experienced a price change of -1.53%. Over the last three months, the change has been -5.85%. Over the past six months, the figure is -56.73%.

help

Is Werewolf Therapeutics (HOWL) a profitable company?

Werewolf Therapeutics (HOWL) has a net income of -$37.37M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 91.15% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.96K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $19.94M, with a revenue growth rate of 21.6%, providing insight into the company's sales performance and growth. The gross profit is $18.18M. Operating income is noted at -$40.5M. Furthermore, the EBITDA is -$64.38M.

help

What is the market capitalization of Werewolf Therapeutics (HOWL)?

Werewolf Therapeutics (HOWL) has a market capitalization of $87.3M. The average daily trading volume is 1.97, indicating the stock's liquidity and investor engagement.

News

WEREWOLF THERAPEUTICS

Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

ANALYST RATINGS

Jun 26, 2024

Where Werewolf Therapeutics Stands With Analysts

HEALTH

Jun 25, 2024

Werewolf Therapeutics Highlights Initial Safety and Efficacy Data from its Ongoing Phase 1 Clinical Trial Evaluating WTX-330 in Patients with Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors

ANALYST RATINGS

May 24, 2024

Critical Insights From Werewolf Therapeutics Analyst Ratings: What You Need To Know

CALENDAR OF EVENTS

HEALTH

PRODUCT / SERVICES ANNOUNCEMENT

CONFERENCE CALLS/ WEBCASTS

CLINICAL STUDY

May 23, 2024

Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About Werewolf Therapeutics (HOWL)

Keep an eye on Werewolf Therapeutics

Frequently Asked Questions

What is Werewolf Therapeutics's (HOWL) price per share?

What is the 52-week high and low for Werewolf Therapeutics (HOWL)?

Is Werewolf Therapeutics (HOWL) a growth stock?

What is Werewolf Therapeutics (HOWL) stock price performance year to date (YTD)?

Is Werewolf Therapeutics (HOWL) a profitable company?

What is the market capitalization of Werewolf Therapeutics (HOWL)?

News

Sign up for our newsletter

Take Your Investments to a Whole New Level